Research - Paris, Île-de-France, France
Olgram is an early stage biotechnology company aiming at fighting antibiotic resistance by developing two programs: i) developing new molecules to boost the immune system of patients to avoid nosocomial diseases and ii) finding new classes of anti infectious molecules.
Gmail
Apache
Google Font API
Mobile Friendly
Google Analytics